InMode Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $36.52
- Today's High:
- $37.87
- Open Price:
- $37.46
- 52W Low:
- $26.1
- 52W High:
- $48.25
- Prev. Close:
- $37.79
- Volume:
- 1103636
Company Statistics
- Market Cap.:
- $3.29 billion
- Book Value:
- 7.987
- Revenue TTM:
- $496.96 million
- Operating Margin TTM:
- 42.59%
- Gross Profit TTM:
- $380.79 million
- Profit Margin:
- 36.77%
- Return on Assets TTM:
- 21.04%
- Return on Equity TTM:
- 32.66%
Company Profile
InMode Ltd had its IPO on 2019-08-08 under the ticker symbol INMD.
The company operates in the Healthcare sector and Medical Devices industry. InMode Ltd has a staff strength of 480 employees.
Stock update
Shares of InMode Ltd opened at $37.46 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $36.52 - $37.87, and closed at $36.65.
This is a -3.02% slip from the previous day's closing price.
A total volume of 1,103,636 shares were traded at the close of the day’s session.
In the last one week, shares of InMode Ltd have slipped by -7.19%.
InMode Ltd's Key Ratios
InMode Ltd has a market cap of $3.29 billion, indicating a price to book ratio of 6.2159 and a price to sales ratio of 6.9857.
In the last 12-months InMode Ltd’s revenue was $496.96 million with a gross profit of $380.79 million and an EBITDA of $212.41 million. The EBITDA ratio measures InMode Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, InMode Ltd’s operating margin was 42.59% while its return on assets stood at 21.04% with a return of equity of 32.66%.
In Q2, InMode Ltd’s quarterly earnings growth was a positive 25% while revenue growth was a positive 19.8%.
InMode Ltd’s PE and PEG Ratio
- Forward PE
- 14.5138
- Trailing PE
- 18.1982
- PEG
- 2.9004
Its diluted EPS in the last 12-months stands at $2.17 per share while it has a forward price to earnings multiple of 14.5138 and a PEG multiple of 2.9004. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into InMode Ltd’s profitability.
InMode Ltd stock is trading at a EV to sales ratio of 6.2073 and a EV to EBITDA ratio of 13.8906. Its price to sales ratio in the trailing 12-months stood at 6.9857.
InMode Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $734.08 million
- Total Liabilities
- $60.73 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $194000
- Dividend Payout Ratio
- 0%
InMode Ltd ended 2024 with $734.08 million in total assets and $0 in total liabilities. Its intangible assets were valued at $734.08 million while shareholder equity stood at $666.16 million.
InMode Ltd ended 2024 with $0 in deferred long-term liabilities, $60.73 million in other current liabilities, in common stock, $0 in retained earnings and $0 in goodwill. Its cash balance stood at $159.86 million and cash and short-term investments were $629.41 million. The company’s total short-term debt was $0 while long-term debt stood at $0.
InMode Ltd’s total current assets stands at $719.21 million while long-term investments were $600000.00 and short-term investments were $469.56 million. Its net receivables were $51.22 million compared to accounts payable of $13.30 million and inventory worth $38.57 million.
In 2024, InMode Ltd's operating cash flow was $0 while its capital expenditure stood at $194000.
Comparatively, InMode Ltd paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $36.65
- 52-Week High
- $48.25
- 52-Week Low
- $26.1
- Analyst Target Price
- $55.4
InMode Ltd stock is currently trading at $36.65 per share. It touched a 52-week high of $48.25 and a 52-week low of $48.25. Analysts tracking the stock have a 12-month average target price of $55.4.
Its 50-day moving average was $40.93 and 200-day moving average was $36.38 The short ratio stood at 5.54 indicating a short percent outstanding of 0%.
Around 1363.1% of the company’s stock are held by insiders while 6238.8% are held by institutions.
Frequently Asked Questions About InMode Ltd
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women’s health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.